Linzess and Lubiprostone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Linzess (linaclotide) and Lubiprostone (lubiprostone). Common drug interactions include pain among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Linzess and Lubiprostone. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Linzess?

Linzess has active ingredients of linaclotide. It is often used in constipation. eHealthMe is studying from 24,086 Linzess users. Check the latest studies of Linzess.

What is Lubiprostone?

Lubiprostone has active ingredients of lubiprostone. eHealthMe is studying from 957 Lubiprostone users. Check the latest studies of Lubiprostone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

41 people who take Linzess and Lubiprostone together, and have interactions are studied.

Linzess and Lubiprostone drug interactions.

What are the common drug interactions of Linzess and Lubiprostone, by gender? *:

female:

  1. Pain
  2. Headache (pain in head)
  3. Diarrhoea
  4. Dizziness
  5. Drug intolerance (drug sensitivity)
  6. Fall
  7. Fungal infection
  8. Hospitalisation
  9. Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
  10. Migraine (headache)

male:

  1. Asthenia (weakness)
  2. Angiopathy (generic term for a disease of the blood vessels)
  3. Fatigue (feeling of tiredness)
  4. Hypersensitivity
  5. Hypoglycaemia (deficiency of glucose in the bloodstream)
  6. Joint stiffness
  7. Snoring
  8. Throat tightness
  9. Anxiety
  10. Arthralgia (joint pain)

What are the common drug interactions of Linzess and Lubiprostone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Angiopathy (generic term for a disease of the blood vessels)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Chest pain
  6. Depression
  7. Disturbance in attention
  8. Dyspnoea (difficult or laboured respiration)
  9. Fatigue (feeling of tiredness)
  10. Hypersensitivity

30-39:

  1. Neuropathy peripheral (surface nerve damage)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Regurgitation (expulsion of material)
  4. Road traffic accident
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Tendonitis (a condition that causes pain and swelling of tendons)
  7. Vertigo
  8. Allergy to arthropod bite
  9. Asthenia (weakness)
  10. Asthma

40-49:

  1. Fungal infection
  2. Headache (pain in head)
  3. Pain
  4. Abdominal pain upper
  5. Pancreatitis (inflammation of pancreas)
  6. Viral pharyngitis (inflammation of the throat or pharynx caused by viral infection)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Migraine (headache)
  9. Abdominal pain
  10. Adverse event

50-59:

  1. Abdominal distension
  2. Abdominal pain
  3. Ageusia (loss of taste functions of the tongue)
  4. Asthenia (weakness)
  5. Dehydration (dryness resulting from the removal of water)
  6. Diarrhoea
  7. Dysgeusia (disorder of the sense of taste)
  8. Eye inflammation
  9. Headache (pain in head)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

60+:

  1. Hospitalisation
  2. Alanine aminotransferase increased
  3. Hypopnoea (decrease in the breathing rate)
  4. Hypotension (abnormally low blood pressure)
  5. Muscle spasms (muscle contraction)
  6. Retching (strong involuntary effort to vomit)
  7. Tendonitis (a condition that causes pain and swelling of tendons)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Urinary retention (the inability to completely or partially empty the bladder)
  10. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

What are the existing conditions these people have? *

  1. Irritable Bowel Syndrome: 6 people, 14.63%
  2. Migraine (headache): 5 people, 12.20%
  3. Drowsiness: 5 people, 12.20%
  4. Pain: 4 people, 9.76%
  5. Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 4 people, 9.76%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 9.76%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 9.76%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 9.76%
  9. Impaired Gastric Emptying: 4 people, 9.76%
  10. Depression: 4 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take Linzess and Lubiprostone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Linzess and Lubiprostone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lubiprostone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linzess and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lubiprostone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on linaclotide and lubiprostone (the active ingredients of Linzess and Lubiprostone, respectively), and Linzess and Lubiprostone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: